Overview
Liver cirrhosis is the advanced, diffuse scarring of the liver in which progressive fibrosis and regenerative nodules replace functional hepatic tissue, distorting the organ's architecture and impairing its synthetic and metabolic roles. It represents the common end stage of chronic liver injury arising from causes such as viral hepatitis, alcohol-related disease, and metabolic and fatty liver disease. A defining consequence is portal hypertension, the rise in pressure within the portal venous system that drives the formation of gastro-oesophageal and gastric varices, ascites, and the risk of variceal haemorrhage; related vascular anomalies such as isolated left gastric vein stenosis can produce similar bleeding. Chronic liver disease also predisposes to hepatocellular carcinoma, where angiogenic markers reflect tumour development on a background of hepatitis infection. Assessment combines clinical, biochemical, and imaging methods, including non-invasive measures of liver stiffness, although such measures do not always correlate with the degree of decompensation or portal hypertension. Research in this area examines the epidemiology and trends of chronic liver disease across populations, the complications of decompensation, the management of hepatitis as an underlying cause, and the diagnostic tools used to stage disease and predict outcome.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Magnitude and Trends of Chronic Liver Disease: A Retrospective Hospital Based Study in Eastern Amhara Region, Northeast Ethiopia
Role of Tie2, CD14, Angiopoietin as Angiogenetic Markers in Hepatocellular Carcinoma Complicating Hepatitis C Virus Infection
Treatment of Chronic Hepatitis B With Tenofovir At The University Teaching Hospital Campus of Lome (Togo)
Cell-Based Vital Organs Specific Biomarkers Assessment using Biofield Energy Based Novel Test Formulation
In Vitro Cell-Based Biomarkers Study of Vital Organs: Impact of the Biofield Energy Based Test Formulation
Liver Stiffness by ARFI does not Correlate with Decompensation and Portal Hypertension in Patients with Cirrhosis
Liver Disease: A Retrospective Hospital Based Study in Addis Ababa-Ethiopia
Impact of Biofield Energy Treatment Based Test Formulation on Vital Organ Health Specific Biomarkers Using Cell Line Study
The Impact of Nutrients on Diabetes
Understanding Inherited Bleeding Disorders: Genetic Mutations in Blood Coagulation Factors and Regulatory Proteins
Pseudotumor Tuberculosis Of Liver: A Rare Entity
How this research is being cited
The 12 articles above have been cited 15 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · BioMed Research International
-
2025 · BMC Gastroenterology
-
2025 · BMC Gastroenterology
-
2024 · Risk Management and Healthcare Policy
-
2024 · Risk Management and Healthcare Policy
-
2024 · Research Square (Research Square)
-
2023 · Journal of Spleen and Liver Research
-
2023 · Journal of Spleen and Liver Research
A sample of recent works citing this journal's research on Liver Cirrhosis, linking to each citing work.